EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H18N6 |
| Net Charge | 0 |
| Average Mass | 306.373 |
| Monoisotopic Mass | 306.15929 |
| SMILES | N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3nccc23)cn1 |
| InChI | InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1 |
| InChIKey | HFNKQEVNSGCOJV-OAHLLOKOSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. antiviral agent A substance that destroys or inhibits replication of viruses. EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2). immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. |
| Applications: | antirheumatic drug A drug used to treat rheumatoid arthritis. antifibrotic agent Any agent which acts to reduce fibrosis. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antipsoriatic A drug used to treat psoriasis. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ruxolitinib (CHEBI:66919) has role anti-anaemic agent (CHEBI:75835) |
| ruxolitinib (CHEBI:66919) has role anti-HIV agent (CHEBI:64946) |
| ruxolitinib (CHEBI:66919) has role antifibrotic agent (CHEBI:233423) |
| ruxolitinib (CHEBI:66919) has role antimicrobial agent (CHEBI:33281) |
| ruxolitinib (CHEBI:66919) has role antineoplastic agent (CHEBI:35610) |
| ruxolitinib (CHEBI:66919) has role antipsoriatic (CHEBI:50748) |
| ruxolitinib (CHEBI:66919) has role antirheumatic drug (CHEBI:35842) |
| ruxolitinib (CHEBI:66919) has role antiviral agent (CHEBI:22587) |
| ruxolitinib (CHEBI:66919) has role dermatologic drug (CHEBI:50177) |
| ruxolitinib (CHEBI:66919) has role EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor (CHEBI:76617) |
| ruxolitinib (CHEBI:66919) has role immunosuppressive agent (CHEBI:35705) |
| ruxolitinib (CHEBI:66919) is a nitrile (CHEBI:18379) |
| ruxolitinib (CHEBI:66919) is a pyrazoles (CHEBI:26410) |
| ruxolitinib (CHEBI:66919) is a pyrrolopyrimidine (CHEBI:38670) |
| Incoming Relation(s) |
| ruxolitinib phosphate (CHEBI:66917) has part ruxolitinib (CHEBI:66919) |
| IUPAC Name |
|---|
| (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
| INN | Source |
|---|---|
| ruxolitinib | KEGG DRUG |
| Synonyms | Source |
|---|---|
| INC-424 | ChEMBL |
| INC424 | ChEMBL |
| INCB-018424 | ChEMBL |
| INCB018424 | ChemIDplus |
| INCB-18424 | ChEMBL |
| Ruxolitinib, s- | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| 4190 | DrugCentral |
| D09959 | KEGG DRUG |
| LSM-1139 | LINCS |
| Ruxolitinib | Wikipedia |
| US2008312258 | Patent |
| US2010190981 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:18703668 | Reaxys |
| CAS:941678-49-5 | KEGG DRUG |
| CAS:941678-49-5 | ChemIDplus |
| Citations |
|---|